144 related articles for article (PubMed ID: 35277319)
21. Experience and analysis of Delphian lymph node metastasis in patients with papillary thyroid carcinoma.
Kim WW; Yang SI; Kim JH; Choi YS; Park YH; Kwon SK
World J Surg Oncol; 2012 Oct; 10():226. PubMed ID: 23110552
[TBL] [Abstract][Full Text] [Related]
22. Predictive factors and pattern of central lymph node metastasis in unilateral papillary thyroid carcinoma.
Ji YB; Yoo HS; Song CM; Park CW; Lee CB; Tae K
Auris Nasus Larynx; 2016 Feb; 43(1):79-83. PubMed ID: 26441368
[TBL] [Abstract][Full Text] [Related]
23. Clinical significance of Delphian lymph node metastasis in papillary thyroid carcinoma.
Oh EM; Chung YS; Lee YD
World J Surg; 2013 Nov; 37(11):2594-9. PubMed ID: 23877804
[TBL] [Abstract][Full Text] [Related]
24. Preoperative BRAF mutation is predictive of occult contralateral carcinoma in patients with unilateral papillary thyroid microcarcinoma.
Zhou YL; Zhang W; Gao EL; Dai XX; Yang H; Zhang XH; Wang OC
Asian Pac J Cancer Prev; 2012; 13(4):1267-72. PubMed ID: 22799316
[TBL] [Abstract][Full Text] [Related]
25. Performing contralateral central lymph node dissection in papillary thyroid carcinoma: a decision approach.
Chae BJ; Jung CK; Lim DJ; Song BJ; Kim JS; Jung SS; Bae JS
Thyroid; 2011 Aug; 21(8):873-7. PubMed ID: 21745104
[TBL] [Abstract][Full Text] [Related]
26. Pretracheal Lymph Node Subdivision in Predicting Contralateral Central Lymph Node Metastasis for Unilateral Papillary Thyroid Carcinoma: Preliminary Results.
Chen Q; Liu Y; Lu W; Zhang L; Su A; Liu F; Zhu J
Front Endocrinol (Lausanne); 2022; 13():921845. PubMed ID: 35923620
[TBL] [Abstract][Full Text] [Related]
27. Delphian lymph node metastasis is a novel indicator of tumor aggressiveness and poor prognosis in papillary thyroid cancer.
Zhu Y; Lin J; Yan Y; Zheng K; Zhang H; Wu K; Kong L; Chen L; Chen X
J Surg Oncol; 2021 Jun; 123(7):1521-1528. PubMed ID: 33713443
[TBL] [Abstract][Full Text] [Related]
28. Prelaryngeal and/or pretracheal lymph node metastasis could help to identify papillary thyroid carcinoma with intermediate risk from unilateral lobe cT1-2N0 papillary thyroid carcinoma.
Wang B; Zhu CR; Fei Y; Liu H; Yao XM; Wu J
Front Endocrinol (Lausanne); 2023; 14():1156664. PubMed ID: 37124749
[TBL] [Abstract][Full Text] [Related]
29. Use of Delphian lymph node metastasis to predict central and lateral involvement in papillary thyroid carcinoma: A systematic review and meta-analysis.
Huang J; Sun W; Zhang H; Zhang P; Wang Z; Dong W; He L; Zhang T
Clin Endocrinol (Oxf); 2019 Jul; 91(1):170-178. PubMed ID: 30851206
[TBL] [Abstract][Full Text] [Related]
30. Significance of multifocality in papillary thyroid carcinoma.
Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
[TBL] [Abstract][Full Text] [Related]
31. High-risk factors for lymph node metastasis in contralateral central compartment in unilateral papillary thyroid carcinoma（cT1N0）.
Zhou B; Qin J
Eur J Surg Oncol; 2021 Apr; 47(4):882-887. PubMed ID: 33092967
[TBL] [Abstract][Full Text] [Related]
32. [Clinical analysis of lymphocytic thyroiditis coexistent with papillary thyroid carcinoma].
Wang SX; She ZQ; An CM; Zhang XW; Li ZJ; Tang PZ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Apr; 51(4):277-81. PubMed ID: 27095720
[TBL] [Abstract][Full Text] [Related]
33. Should multifocality be an indication for prophylactic central neck dissection in papillary thyroid cancer?
Ozdemir K; Harmantepe AT; Gonullu E; Kocer B; Bayhan Z
Updates Surg; 2023 Apr; 75(3):701-706. PubMed ID: 36871277
[TBL] [Abstract][Full Text] [Related]
34. Predictive factors of contralateral occult carcinoma in patients with papillary thyroid carcinoma: a retrospective study.
Chen X; Zhong Z; Song M; Yuan J; Huang Z; Du J; Liu Y; Wu Z
Gland Surg; 2020 Aug; 9(4):872-878. PubMed ID: 32953595
[TBL] [Abstract][Full Text] [Related]
35. Lateral neck metastases in the ipsilateral and contralateral compartments of papillary thyroid carcinoma located in one lobe.
Kim SY; Kim SM; Chang H; Kim BW; Lee YS; Chang HS; Park CS
ANZ J Surg; 2019 Nov; 89(11):E498-E501. PubMed ID: 31566299
[TBL] [Abstract][Full Text] [Related]
36. Predictive factors for occult contralateral carcinoma in patients with unilateral papillary thyroid microcarcinoma by preoperative ultrasonographic and pathological features.
Lee YC; Eun YG; Sohn YM; Rhee SY; Hong IK; Chon S; Oh SJ; Kim DY
World J Surg; 2015 Jul; 39(7):1736-41. PubMed ID: 25743485
[TBL] [Abstract][Full Text] [Related]
37. Prediction of occult central lymph node metastasis in papillary thyroid carcinoma by preoperative BRAF analysis using fine-needle aspiration biopsy: a prospective study.
Joo JY; Park JY; Yoon YH; Choi B; Kim JM; Jo YS; Shong M; Koo BS
J Clin Endocrinol Metab; 2012 Nov; 97(11):3996-4003. PubMed ID: 22930785
[TBL] [Abstract][Full Text] [Related]
38. The BRAFT1799A mutation is not associated with occult contralateral carcinoma in patients with unilateral papillary thyroid microcarcinoma.
Wan HF; Zhang B; Yan DG; Xu ZG
Asian Pac J Cancer Prev; 2015; 16(7):2947-51. PubMed ID: 25854387
[TBL] [Abstract][Full Text] [Related]
39. Predictive Factors for Occult Bilateral Papillary Thyroid Carcinoma.
Wang N; Qian LX
Acad Radiol; 2021 Mar; 28(3):328-332. PubMed ID: 32253114
[TBL] [Abstract][Full Text] [Related]
40. Pattern and Predictive Factors of Metastasis in Lymph Nodes Posterior to the Right Recurrent Laryngeal Nerve in Papillary Thyroid Carcinoma.
Zhou M; Duan Y; Ye B; Wang Y; Li H; Wu Y; Chen P; Zhu J; Jing C; Wu Y; Wang X
Front Endocrinol (Lausanne); 2022; 13():914946. PubMed ID: 35923627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
